Position in VRTX
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$489,775
+$79,405 QoQ
Shares Held
986
+7.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#1,088
of 1,735 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026EVERPAR ADVISORS LLC holds $767,250 across 2 Biotechnology names. VRTX ranks #1 (63.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
986 | $489,775 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
445 | $277,475 |
All Filings in VRTX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $489,775 | 986 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $410,370 | 919 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $361,781 | 798 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $294,904 | 753 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $352,598 | 792 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $362,645 | 748 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $268,600 | 667 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $322,300 | 693 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $439,190 | 937 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $229,905 | 550 | Shares | Sole | 2024-04-22 | |
| No filing history on record for this holder in this stock. | ||||||